High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features

ConclusionsPD-L1 is expressed in 59.3% of GC patients and is associated with MSI and EBV positivity. These results provide a basis for identifying GC patients who may benefit from anti-PD-1/PD-L1 therapy.
Source: Pathology Research and Practice - Category: Pathology Source Type: research